BridgeBio Pharma Inc. (BBIO) stock
Price, quality score, analyst targets, a 30-day Kronos AI forecast and a Shariah screen for BridgeBio Pharma Inc., updated every trading day.
Health Care · Biotechnology: Pharmaceutical Preparations
Price
$70.82
+2.09% today
Market cap
$13.6B
Overall quality
45/100
Kronos AI 30-day
+0.6%
4 of 8 simulated paths end higher
BridgeBio Pharma Inc. (BBIO) is a Health Care company in Biotechnology: Pharmaceutical Preparations, worth $13.6B. It trades at $70.82, up 2.09% today. Its overall quality score is 45 out of 100, ranked against the whole US market. 18 analysts' average target of $109.65 implies +54.8% from today's price. Kronos AI's 30-day forecast is +0.6% (4 of 8 simulated paths end higher).
Open the full interactive analysis →Charts, technical signals, DCF fair value and ownership
Analyst price targets
| Average target | $109.65 |
| Low – high | $87.00 – $156.00 |
| Analysts | 18 |
| Upside to average | +54.8% |
Kronos AI 30-day forecast
| Expected close | $69.78 (+0.6%) |
| Likely range | −2.6% … +12.1% |
| As of | 2026-10-27 |
4 of 8 simulated paths end higher.
Quality scores
| Profitability | 25 |
| Solvency | 36 |
| Growth | 74 |
| Overall | 45 |
| P/E | — |
Shariah screen
| Business activity | Passes |
| Debt and cash (AAOIFI 30%) | Not checked for this listing |
Automated screen of business activity and AAOIFI's 30% debt and cash limits. The 5% impermissible-income test is not applied. Check with a scholar before deciding.
Halal Health Care stocks · Zakat calculator · Purification calculator
Similar companies in Biotechnology: Pharmaceutical Preparations
For information only, not investment advice. Prices updated: 2026-10-29.